Cargando…
Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression
Neuroblastoma (NB) is a highly aggressive extracranial solid tumor in children. Due to its heterogeneity, NB remains a therapeutic challenge. Several oncogenic factors, including the Hippo effectors YAP/TAZ, are associated with NB tumorigenesis. Verteporfin (VPF) is an FDA-approved drug shown to dir...
Autores principales: | Condurat, Alexandra-Larisa, Aminzadeh-Gohari, Sepideh, Malnar, Mirjana, Schider, Nicole, Opitz, Leonie, Thomas, Ria, Menon, Vishal, Kofler, Barbara, Pruszak, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992669/ https://www.ncbi.nlm.nih.gov/pubmed/36882436 http://dx.doi.org/10.1038/s41598-023-29796-2 |
Ejemplares similares
-
The Hippo pathway member YAP enhances human neural crest cell fate and migration
por: Hindley, Christopher J., et al.
Publicado: (2016) -
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021) -
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation
por: Ferlemann, Fraua Christina, et al.
Publicado: (2017) -
Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023) -
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
por: Wei, Lina, et al.
Publicado: (2023)